BofA Securities Downgrades Apellis Pharmaceuticals (APLS)to Neutral, 'safety events still rare but further color needed'
Tweet Send to a Friend
(Updated - August 1, 2023 6:12 AM EDT)
BofA Securities analyst Tazeen Ahmad downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
